Clinical Trial Update: Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection Fraction [NA]

View source ↗

Summary

A completed clinical trial evaluated neuromodulation for treating heart failure with preserved ejection fraction; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: University of Oklahoma | Conditions: Heart Failure With Normal Ejection Fraction | NA | Status: COMPLETED | Results posted: 2022-09-22